Castleview Partners, LLC Edwards Lifesciences Corp Transaction History

Castleview Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$69.28 - $93.38 $4,433 - $5,976	-64 Reduced 21.55%	233 $16,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $22,055 - $25,099	297 New	297 $24,000
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $174,706 - $227,562	-2,121 Reduced 81.33%	487 $40,000
Q2 2022 Aug 17, 2022	SELL	$86.5 - $128.27 $3.78 Million - $5.61 Million	-43,700 Reduced 94.37%	2,608 $247,000
Q2 2022 Aug 16, 2022	BUY	$86.5 - $128.27 $3.94 Million - $5.85 Million	45,586 Added 6313.85%	46,308 $4.4 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $7.9 Million - $9.95 Million	-77,526 Reduced 99.08%	722 $84,000
Q4 2021 Feb 17, 2022	BUY	$106.37 - $130.68 $8.32 Million - $10.2 Million	78,248 New	78,248 $10.1 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.